Oric Pharmaceuticals Stock Investor Sentiment
| ORIC Stock | USD 7.51 0.04 0.54% |
About 52% of Oric Pharmaceuticals' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Oric Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with Oric Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Oric Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Comfort Level 52
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Oric Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Oric Pharmaceuticals.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentDisposing |
Oric Historical Sentiment
Although Oric Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Oric, such as negative comments on social media and news outlets, may cause fear in the market and push Oric Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Oric.
Oric |
Oric Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Oric Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Oric Pharmaceuticals that are available to investors today. That information is available publicly through Oric media outlets and privately through word of mouth or via Oric internal channels. However, regardless of the origin, that massive amount of Oric data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oric Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oric Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oric Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oric Pharmaceuticals alpha.
Oric Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Chacko Jacob of 300000 shares of Oric Pharmaceuticals at 4.36 subject to Rule 16b-3 | 12/27/2024 |
2 | Acquisition by Chacko Jacob of 100000 shares of Oric Pharmaceuticals subject to Rule 16b-3 | 01/02/2025 |
3 | ORIC Pharmaceuticals Sees Unusually-High Trading Volume - Whats Next - MarketBeat | 01/07/2025 |
4 | ORIC Pharmaceuticals Shares Up 5.6 percent - Should You Buy - MarketBeat | 01/24/2025 |
5 | Acquisition by Kunkel Lori Anne of 25600 shares of Oric Pharmaceuticals at 7.9 subject to Rule 16b-3 | 01/27/2025 |
6 | Citi maintains ORIC stock Buy rating, 13 target ahead of PFE data - MSN | 02/04/2025 |
7 | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635 | 02/07/2025 |
8 | JPMorgan Chase Co. Forecasts Strong Price Appreciation for ORIC Pharmaceuticals Stock - MarketBeat | 02/10/2025 |
9 | Buy Rating on Oric Pharmaceuticals Capitalizing on Prostate Cancer Treatment Advances - TipRanks | 02/14/2025 |
10 | ORICPharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates | 02/18/2025 |
11 | ORIC Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones | 02/25/2025 |
12 | Acquisition by Chacko Jacob of 600000 shares of Oric Pharmaceuticals at 8.26 subject to Rule 16b-3 | 02/28/2025 |
13 | Brokerages Set ORIC Pharmaceuticals, Inc. Target Price at 18.86 - MarketBeat | 03/05/2025 |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |